免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

ExoAtlet-II

K号: K201473 · 2021-07-16

决定日期2021-07-16
产品代码PHL
咨询委员会PM 请注意,由于您没有提供具体的医疗设备监管文本,我无法进行翻译。请提供具体的文本内容,以便我能够按照您的要求进行翻译。
决定实质等同

器械摘要

ExoAtlet-II is the device name listed in this FDA 510(k) record. The listed applicant is Exoatlet Asia Co. , Ltd.. It received FDA 510(k) clearance on 2021-07-16 under 510(k) number K201473. The device is classified under product code PHL. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the ExoAtlet-II?

ExoAtlet-II is a medical device that received FDA 510(k) clearance on 2021-07-16. The listed applicant is Exoatlet Asia Co. , Ltd.. The 510(k) number is K201473.

When did ExoAtlet-II receive FDA 510(k) clearance?

ExoAtlet-II received FDA 510(k) clearance on 2021-07-16, under 510(k) number K201473.

Who is the listed applicant for ExoAtlet-II?

The FDA 510(k) record lists Exoatlet Asia Co. , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ExoAtlet-II?

The FDA product code for ExoAtlet-II is PHL.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:PHL)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑